Paper3933532
The effects of cyclosporin A on the immune system.
Shevach EM. Annu Rev Immunol, 1985. Cited by 621 papers, by iCite.
Cite this record
ConductScience Library. The effects of cyclosporin A on the immune system. Papers, record 3933532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3933532
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclosporins | Major topic |
| Immune System | Major topic |
| Animals | |
| Autoimmune Diseases | |
| B-Lymphocytes | |
| Clone Cells | |
| Graft Rejection | |
| Humans | |
| Hybridomas | |
| In Vitro Techniques | |
| Interleukin-2 | |
| Lymphocyte Activation | |
| Lymphokines | |
| Mice | |
| Receptors, Immunologic | |
| Receptors, Interleukin-2 | |
| T-Lymphocytes | |
| Transplantation, Homologous |
Source PubMed
Cited by115
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 621 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35739412 | Mitochondrial Permeability Transition in Stem Cells, Development, and Disease. | Adv Exp Med Biol | 2023 | https://conductscience.org/library/papers/35739412 | PubMed |
| 35224236 | Protein-protein interface analysis of the non-ribosomal peptide synthetase peptidyl carrier protein and enzymatic domains. | Synth Syst Biotechnol | 2022 | https://conductscience.org/library/papers/35224236 | PubMed |
| 34552938 | Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34552938 | PubMed |
| 33337128 | l-Threonine Transaldolase Activity Is Enabled by a Persistent Catalytic Intermediate. | ACS Chem Biol | 2021 | https://conductscience.org/library/papers/33337128 | PubMed |
| 30984176 | Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications. | Front Immunol | 2019 | https://conductscience.org/library/papers/30984176 | PubMed |
| 29892147 | In Vivo Comparative Evaluation of the Pomegranate (Punica granatum) Peel Extract as an Alternative Agent to Nystatin against Oral Candidiasis. | Iran J Med Sci | 2018 | https://conductscience.org/library/papers/29892147 | PubMed |
| 27358055 | The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats. | Am J Physiol Renal Physiol | 2016 | https://conductscience.org/library/papers/27358055 | PubMed |
| 25902927 | Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques. | Clin Exp Immunol | 2015 | https://conductscience.org/library/papers/25902927 | PubMed |
| 24216163 | Immunosuppressive activity of an aqueous Viola tricolor herbal extract. | J Ethnopharmacol | 2014 | https://conductscience.org/library/papers/24216163 | PubMed |
| 23840803 | Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism. | PLoS One | 2013 | https://conductscience.org/library/papers/23840803 | PubMed |
| 23406403 | Heteropterys tomentosa (A. Juss.) infusion counteracts Cyclosporin a side effects on the ventral prostate. | BMC Complement Altern Med | 2013 | https://conductscience.org/library/papers/23406403 | PubMed |
| 21562466 | Consecutive low doses of cyclosporine A induce pro-inflammatory cytokines and accelerate allograft skin rejection. | Molecules | 2011 | https://conductscience.org/library/papers/21562466 | PubMed |
| 21035406 | CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. | Cancer Cell | 2010 | https://conductscience.org/library/papers/21035406 | PubMed |
| 20300548 | The dual role of calcium as messenger and stressor in cell damage, death, and survival. | Int J Cell Biol | 2010 | https://conductscience.org/library/papers/20300548 | PubMed |
| 16622732 | High-turnover osteoporosis is induced by cyclosporin A in rats. | J Bone Miner Metab | 2006 | https://conductscience.org/library/papers/16622732 | PubMed |
| 15493267 | The phenotypic and molecular characterization of Nb2 lymphoma cells activated with IL-2 and human growth hormone. | Immunology | 1989 | https://conductscience.org/library/papers/15493267 | PubMed |
| 14592756 | Vacuolating encephalitis in mice infected by human coronavirus OC43. | Virology | 2003 | https://conductscience.org/library/papers/14592756 | PubMed |
| 12827216 | Effects of immunomodulators on airways hyperresponsiveness to adenosine induced in actively sensitised Brown Norway rats by exposure to allergen. | Naunyn Schmiedebergs Arch Pharmacol | 2003 | https://conductscience.org/library/papers/12827216 | PubMed |
| 12412760 | Immunosuppression with cyclosporin A alters the thymic microenvironment. | Clin Exp Immunol | 1989 | https://conductscience.org/library/papers/12412760 | PubMed |
| 11683964 | Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity. | Immunology | 2001 | https://conductscience.org/library/papers/11683964 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3933532
GET https://conductscience.org/api/papers/v1/3933532/cited_by?page=2